All immune responses depend on antigens stimulating specific lymphocyte cells to become activated. This process involves a small, non-dividing cell enlarging, dividing several times, and building a secretory factory in the cytoplasm. For the B lymphocyte, the secreted product is an antibody. for an immune response to be appropriate to the stimulus, be this an infection or a vaccination, every step in this elaborate activation pathway needs to be controlled or fine-tuned.
Our research aims to dissect the steps of activation and thus to understand the cellular mechanisms underlying antibody formation. This understanding will help the design of new and improved vaccines, and will allow deeper insights into autoimmune diseases. B lymphocytes will be obtained from the spleens and other lymphoid organs of mice. They will be fractionated by procedures that allow the isolation of cells predestined to form antibody only to a particular antigen of choice. Through microculture techniques, these antigen-specific B cells will be cultured as single cells over a 5 to 6-day period. They will be stimulated by controlled amounts of the antigen with which they are reactive, aided by one or more pure growth factors called interleukins or IL. Specifically, IL-4, IL-5, IL-6, IL-1 and IL-2 will be used both as single agents and in various permutations and combinations. Activation of single small B cells will be monitored microscopically through measured enlargement. Division will be noted through repeated microscopy. Antibody formation will be studied by assay of the microculture fluid, both for amount and for chemical kind or isotype"""""""". The project will have 4 linked aims. First, we shall establish exactly which phase of the activation cascade is controlled by which interleukin. Secondly, we will study mice that have been """"""""tricked"""""""" into treating the foreign antigen as though it were part of the body itself (i.e. rendered immunologically tolerant) in the hope of defining more precisely the cellular mechanisms for self- recognition. Thirdly, we will examine different varieties (subsets) of B lymphocytes to see how and why they respond differentially to activation signals. Fourthly, we will investigate the regulated appearance and disappearance of specific protein receptors at the B cell surface for the various interleukins that control their growth and development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI003958-28
Application #
3124162
Study Section
Immunobiology Study Section (IMB)
Project Start
1978-06-01
Project End
1991-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
28
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Walter and Eliza Hall Institute Medical Research
Department
Type
DUNS #
City
Victoria
State
Country
Australia
Zip Code
3050
Nossal, G J V; Pike, Beverley L (2007) Evidence for the clonal abortion theory of B-lymphocyte tolerance. 1975. J Immunol 179:5619-32
Janas, M L; Hodgkin, P; Hibbs, M et al. (1999) Genetic evidence for Lyn as a negative regulator of IL-4 signaling. J Immunol 163:4192-8
Ridderstad, A; Tarlinton, D M (1998) Kinetics of establishing the memory B cell population as revealed by CD38 expression. J Immunol 160:4688-95
Smith, K G; Tarlinton, D M; Doody, G M et al. (1998) Inhibition of the B cell by CD22: a requirement for Lyn. J Exp Med 187:807-11
Tarlinton, D (1998) Germinal centers: form and function. Curr Opin Immunol 10:245-51
Tarlinton, D M; Light, A; Nossal, G J et al. (1998) Affinity maturation of the primary response by V gene diversification. Curr Top Microbiol Immunol 229:71-83
Smith, K G; Light, A; Nossal, G J et al. (1997) The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response. EMBO J 16:2996-3006
Ridderstad, A; Tarlinton, D M (1997) B cell memory in xid mice is long-lived despite reduced memory B cell frequency. Scand J Immunol 45:655-9
Pulendran, B; van Driel, R; Nossal, G J (1997) Immunological tolerance in germinal centres. Immunol Today 18:27-32
Tarlinton, D M; Smith, K G (1997) Apoptosis and the B cell response to antigen. Int Rev Immunol 15:53-71

Showing the most recent 10 out of 85 publications